BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 17511113)

  • 1. Anaplastic Large Cell Lymphoma.
    Medeiros LJ; Elenitoba-Johnson KS
    Am J Clin Pathol; 2007 May; 127(5):707-22. PubMed ID: 17511113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
    Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A; Otsuki T; Vogelbruch M; Clark HM; Jaffe ES; Raffeld M
    Blood; 1995 Sep; 86(6):2321-8. PubMed ID: 7662979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative.
    Ganapathi KA; Nicolae A; Egan C; Geng H; Xi L; Pack SD; McFadden JR; Raffeld M; Jaffe ES; Pittaluga S
    Br J Haematol; 2024 May; 204(5):1862-1871. PubMed ID: 38613165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
    Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
    Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting with spontaneous splenic rupture: an extremely unusual presentation.
    Hebeda KM; MacKenzie MA; van Krieken JH
    Virchows Arch; 2000 Oct; 437(4):459-64. PubMed ID: 11097375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
    ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ
    Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
    Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
    Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.
    Haralambieva E; Pulford KA; Lamant L; Pileri S; Roncador G; Gatter KC; Delsol G; Mason DY
    Br J Haematol; 2000 Jun; 109(3):584-91. PubMed ID: 10886208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
    Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
    Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK+ lymphoma: clinico-pathological findings and outcome.
    Falini B; Pileri S; Zinzani PL; Carbone A; Zagonel V; Wolf-Peeters C; Verhoef G; Menestrina F; Todeschini G; Paulli M; Lazzarino M; Giardini R; Aiello A; Foss HD; Araujo I; Fizzotti M; Pelicci PG; Flenghi L; Martelli MF; Santucci A
    Blood; 1999 Apr; 93(8):2697-706. PubMed ID: 10194450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
    Nakamura S; Shiota M; Nakagawa A; Yatabe Y; Kojima M; Motoori T; Suzuki R; Kagami Y; Ogura M; Morishima Y; Mizoguchi Y; Okamoto M; Seto M; Koshikawa T; Mori S; Suchi T
    Am J Surg Pathol; 1997 Dec; 21(12):1420-32. PubMed ID: 9414185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology.
    Kansal R; Sait SN; Block AW; Ward PM; Kelly FL; Cheney RT; Czuczman M; Brecher ML; Barcos M
    Mod Pathol; 2005 Feb; 18(2):235-43. PubMed ID: 15475930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype.
    Suzuki R; Kagami Y; Takeuchi K; Kami M; Okamoto M; Ichinohasama R; Mori N; Kojima M; Yoshino T; Yamabe H; Shiota M; Mori S; Ogura M; Hamajima N; Seto M; Suchi T; Morishima Y; Nakamura S
    Blood; 2000 Nov; 96(9):2993-3000. PubMed ID: 11049976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation.
    Sasaki K; Sugaya M; Fujita H; Takeuchi K; Torii H; Asahina A; Tamaki K
    Br J Dermatol; 2004 Jun; 150(6):1202-7. PubMed ID: 15214912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of expression of CD44v6 with systemic anaplastic large cell lymphoma: comparison with primary cutaneous anaplastic large cell lymphoma.
    Liang X; Golitz LE; Smoller BR; Meech SJ; Odom LF; Williams SA; Ryder JW
    Am J Clin Pathol; 2002 Feb; 117(2):276-82. PubMed ID: 11863224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (ALK)-negative, anaplastic large-cell lymphoma (ALCL).
    Mencía-Gutiérrez E; Gutiérrez-Díaz E; Salamanca J; Martínez-González MA
    Int J Dermatol; 2006 Jun; 45(6):766-9. PubMed ID: 16796648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALK-positive lymphoma: a single disease with a broad spectrum of morphology.
    Benharroch D; Meguerian-Bedoyan Z; Lamant L; Amin C; Brugières L; Terrier-Lacombe MJ; Haralambieva E; Pulford K; Pileri S; Morris SW; Mason DY; Delsol G
    Blood; 1998 Mar; 91(6):2076-84. PubMed ID: 9490693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
    Cataldo KA; Jalal SM; Law ME; Ansell SM; Inwards DJ; Fine M; Arber DA; Pulford KA; Strickler JG
    Am J Surg Pathol; 1999 Nov; 23(11):1386-92. PubMed ID: 10555007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.